Alport syndrome is an inherited disorder affecting the type IV collagen found in the basement membranes of the kidneys, inner ears, and eyes. It can cause persistent blood in the urine, proteinuria, progressive kidney disease, hearing loss, and certain eye abnormalities. The condition is associated with changes in the COL4A3, COL4A4, or COL4A5 genes. There is currently no routine treatment that corrects the underlying genetic cause. Treatment instead focuses on protecting kidney function, managing complications, monitoring hearing and vision, and addressing advanced kidney disease when necessary.
Kidney Protection
Protecting kidney function is the central part of Alport syndrome treatment.
Medications that block the renin-angiotensin system, particularly ACE inhibitors or angiotensin receptor blockers (ARBs), can reduce proteinuria and help delay progression toward end-stage kidney disease.
The timing of treatment depends on the genetic form of Alport syndrome, age, urine findings, blood pressure, and other clinical factors. Treatment should therefore be determined by a nephrologist rather than started without medical supervision.
Monitoring Proteinuria
Protein in the urine is an important indicator of kidney involvement and disease progression.
Monitoring may include:
- Urine albumin-to-creatinine testing
- Urine protein-to-creatinine testing
- Blood pressure measurements
- Blood creatinine and kidney-function testing
- Regular nephrology appointments
GeneReviews recommends regular kidney monitoring, with frequency influenced by urine protein or albumin levels.
Blood Pressure Management
High blood pressure can place additional stress on damaged kidneys. Maintaining blood pressure within the range recommended by the healthcare team is therefore an important component of treatment.
ACE inhibitors or ARBs may provide both blood-pressure control and kidney protection when appropriate.
Advanced Kidney Disease
Some forms of Alport syndrome can eventually progress to advanced chronic kidney disease or end-stage kidney disease.
When kidney function becomes severely impaired, treatment may involve:
- Hemodialysis
- Peritoneal dialysis
- Kidney transplantation
Kidney transplantation is an established treatment for end-stage kidney disease associated with Alport syndrome. Potential living related donors require particularly careful evaluation because relatives may carry the same genetic condition.
Hearing Loss Treatment
Sensorineural hearing loss is a characteristic feature of some forms of Alport syndrome.
Hearing loss often affects higher frequencies initially and may become noticeable during childhood or adolescence in some affected individuals.
Treatment can include:
- Hearing aids
- Audiology assessments
- Educational support when needed
- Other hearing-support technologies when appropriate
Regular hearing evaluations can help identify changes before communication becomes significantly affected.
Eye Care
Alport syndrome can also cause characteristic eye abnormalities, including anterior lenticonus and certain retinal changes. Some eye findings may cause few symptoms initially.
Regular ophthalmologic examinations can monitor for:
- Lens abnormalities
- Retinal changes
- Corneal problems
- Cataracts
Cataract removal may be considered when cataracts significantly affect vision.
Genetic Counseling
Because Alport syndrome is inherited, genetic counseling can help explain the inheritance pattern and implications for family members.
Genetic testing can identify disease-causing variants in COL4A3, COL4A4, or COL4A5. Testing at-risk relatives can help identify individuals who may benefit from kidney, hearing, and vision monitoring.
Lifestyle Considerations
Lifestyle measures do not cure Alport syndrome, but they can support general kidney health.
Important considerations include:
- Avoiding dehydration
- Maintaining healthy blood pressure
- Following the kidney specialist's dietary recommendations
- Avoiding unnecessary medications that may harm the kidneys
- Keeping scheduled medical appointments
- Protecting hearing from excessive noise
Specific dietary restrictions should be based on kidney function and individual medical advice rather than applying the same diet to everyone with Alport syndrome.
Regular Medical Monitoring
Long-term surveillance is an important part of Alport syndrome management.
Kidney monitoring generally includes urine testing, blood-pressure measurement, and assessment of kidney function. Hearing evaluations are commonly performed every one to two years beginning in childhood, depending on the individual's risk. Eye examinations are also recommended for certain higher-risk groups.
Monitoring allows treatment to begin or change when proteinuria, hypertension, reduced kidney function, hearing changes, or eye abnormalities develop.
Emerging Treatments
Research into Alport syndrome continues to investigate therapies that could slow kidney disease more effectively or address the underlying genetic and molecular abnormalities.
Potential approaches under investigation include:
- New kidney-protective medicines
- Combination therapies
- Molecular treatments
- Gene-based approaches
These approaches should be distinguished from established treatments. Research therapies may only be accessible through appropriate clinical trials.
Prognosis
The outlook varies considerably according to the genetic form of Alport syndrome and the specific disease-causing variant.
Some people experience relatively mild disease, while others develop progressive kidney failure. X-linked Alport syndrome in males and autosomal recessive Alport syndrome can have a higher risk of significant kidney disease, whereas progression may be slower in many individuals with autosomal dominant disease.
Early identification of proteinuria and appropriate kidney-protective treatment can help delay progression.
Conclusion
Alport syndrome treatment focuses primarily on protecting kidney function and managing hearing and eye complications. ACE inhibitors or ARBs are important kidney-protective treatments because they can reduce proteinuria and delay progression toward end-stage kidney disease. Advanced kidney failure may require dialysis or kidney transplantation.